Overseas Headlines – May 8, 2020

United States:

U.S. Jobless Rate Triples to 14.7% in Sharpest Labor Downturn

“In the harshest downturn for American workers in U.S. history, employers cut an unprecedented 20.5 million jobs in April and the unemployment rate more than tripled to 14.7%. Back in February, before the coronavirus pandemic brought the U.S. economy to a standstill, the rate hovered at just 3.5%. That had been the lowest level in five decades. April’s is the highest since just after the Great Depression of the 1930s.”

https://www.bloomberg.com/news/articles/2020-05-08/u-s-jobless-rate-triples-to-14-7-in-sharpest-labor-downturn?srnd=premium

Europe:

Euro Area’s Small Businesses Fear Pandemic Will Cost Them Loans

“Euro-area small businesses entered the coronavirus lockdown fretting about losing access to bank loans because of the damage to their finances, according to the European Central Bank. Small and medium-sized companies, the backbone of the 19-nation economy, saw their own financial situation as one factor impeding their ability to secure credit for the first time since 2014, an ECB survey showed on Friday.”

https://www.bloomberg.com/news/articles/2020-05-08/euro-area-s-small-businesses-fear-pandemic-will-cost-them-loans?srnd=premium-europe

Asia:

Singapore’s Late Pivot to Mass Tests Challenged by Kit Shortage

“In a back room of Singaporean dentist Teehee Dental Works, three orange-topped boxes hum with a sterile buzz. Over the next three hours, a thousand strands of liquid resin will form and harden to become plastic nasal swabs, ready to be used in Covid-19 test kits. Those 3D printers – normally making dentures and crowns – are a part of a local effort to re-tool some of Singapore’s industries to respond to a growing need for test kits amid the widening coronavirus pandemic.”

https://www.bloomberg.com/news/articles/2020-05-08/singapore-s-nasal-swab-struggle-shows-why-test-kits-are-scarce?srnd=premium-asia

 

Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

2020-05-08T08:18:32-05:00